Physician profile
Michael David Decourcey
NPI 1477042711
$13,709.68
in general payments reported to CMS, 2019-2025
26 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $500 · 2023: $745 · 2024: $2,216 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,000 · Food and Beverage: $4,927 · Travel and Lodging: $2,276 · Education: $5.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,000.00 |
| Food and Beverage | $4,927.48 |
| Travel and Lodging | $2,275.99 |
| Education | $5.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $8,915.11 | 2024-2025 | Envista Mx60 Iol, Miebo, Xiidra |
| Tarsus Pharmaceuticals, INC. | $756.34 | 2024-2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $582.02 | 2023-2025 | Tecnis Iol, Tecnis Simplicity, Veritas Vision System |
| Carl Zeiss Meditec USA, INC. | $551.10 | 2023-2024 | Visumax |
| Alcon Vision LLC | $547.33 | 2022-2025 | Wavelight Refractive Suite, Hydrus Microstent, Centurion |
| Sun Pharmaceutical Industries INC. | $402.47 | 2023-2025 | Cequa, Xelpros |
| Glaukos Corporation | $388.15 | 2024-2025 | Idosetr, Radius, Istent |
| New World Medical,INC. | $258.61 | 2023-2024 | Ahmed Glaucoma Valve, Clearpath, Kahook Dual Blade |
| Oyster Point Pharma, INC. | $149.30 | 2022-2024 | Tyrvaya, Ryzumvi |
| Abbvie INC. | $121.55 | 2022-2025 | Xen Glaucoma Treatment System, Vuity |
| Genentech USA, INC. | $116.58 | 2022 | |
| Rayner Intraocular Lenses Limited | $114.04 | 2024-2025 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Biotissue Holdings INC. | $113.49 | 2025 | |
| Horizon Therapeutics Plc | $110.73 | 2022 | |
| Alimera Sciences, INC. | $107.42 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $103.58 | 2024-2025 | Vevye, Iheezo |
| Mallinckrodt Hospital Products INC. | $103.32 | 2024-2025 | Acthar |
| Nova Eye, INC. | $77.66 | 2024 | |
| Ani Pharmaceuticals, INC. | $43.80 | 2025 | Purified Cortrophin Gel |
| Carl Zeiss Meditec, INC. | $36.11 | 2023 | |
| Ocular Therapeutix, INC. | $24.51 | 2024 | Dextenza |
| Dompe US, INC. | $22.76 | 2025 | Oxervate |
| Thea Pharma INC. | $20.14 | 2025 | Iyuzeh |
| Rxsight INC | $16.79 | 2022 | |
| Sight Sciences, INC. | $14.53 | 2024 | Omni Surgical System |
| Merck Sharp & Dohme LLC | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Decourcey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.